Joseph, Mark W.
Stein, Deborah R.
Stein, Adam C.
Funding for this research was provided by:
Horizon Therapeutics
Article History
Received: 18 August 2023
Revised: 18 October 2023
Accepted: 20 October 2023
First Online: 23 February 2024
Declarations
:
: M. W. Joseph, D. R. Stein, and A. C. Stein have received consulting fees from Horizon Therapeutics plc for advisory activities. M. W. Joseph has received honoraria from Horizon for speaking activities. A. C. Stein has received honoraria for speaking and advisory activities from AbbVie, Pfizer, and Takeda Pharmaceuticals.
: The authors confirm independence from the sponsor; the content of the article has not been influenced by the sponsor. No authors received compensation for the preparation of this manuscript.